UC Davis Comprehensive Cancer Center http://www.ucdmc.ucdavis.edu/publish/rss/{$key} UC Davis Comprehensive Cancer Center news UC Davis Comprehensive Cancer Center http://www.ucdmc.ucdavis.edu/global/images/wordmarks/cancer_center.gif http://www.ucdmc.ucdavis.edu/publish/rss/cancercenter UC Davis Comprehensive Cancer Center news UC Davis researchers awarded grant for HIV clinical trial using stem cells http://www.ucdmc.ucdavis.edu/publish/news/cancer/10204/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_10204 SACRAMENTO, Calif. (July 23, 2015) - The state stem cell agency, the California Institute for Regenerative Medicine (CIRM), today approved funding a UC Davis Health System research team to conduct a clinical trial using bioengineered stem cells to treat HIV patients suffering from lymphoma, one of the deadly conditions associated with the disease. Thu, 23 Jul 2015 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/10204 Susan Mar 2015-07-23T00:00:00Z One of America's top hospitals http://www.ucdmc.ucdavis.edu/publish/news/cancer/10186/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_10186 SACRAMENTO, Calif. (July 21, 2015) - UC Davis medical Center has again ranked as one of the best hospitals in the U.S. for 2015-16 in 10 adult medical specialties by U.S. News & World Report. Tue, 21 Jul 2015 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/10186 Susan Mar 2015-07-21T00:00:00Z Radiation Oncology faculty earn key leadership roles http://www.ucdmc.ucdavis.edu/publish/news/cancer/10158/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_10158 SACRAMENTO, Calif. (July 10, 2015) - Two faculty members of the UC Davis Department of Radiation Oncology have been recognized for their leadership and expertise in cancer research and care. Fri, 10 Jul 2015 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/10158 Dorsey Griffith 2015-07-10T00:00:00Z UC Davis researchers find key mechanism that causes neuropathic pain http://www.ucdmc.ucdavis.edu/publish/news/cancer/10142/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_10142 Davis, Calif. (July 6, 2015) - Scientists at the University of California, Davis, have identified a key mechanism in neuropathic pain. The discovery could eventually benefit millions of patients with chronic pain from trauma, diabetes, shingles, multiple sclerosis or other conditions that cause nerve damage. Mon, 06 Jul 2015 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/10142 Susan Mar 2015-07-06T00:00:00Z Knoepfler awarded childhood cancer research grant http://www.ucdmc.ucdavis.edu/publish/news/cancer/10118/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_10118 SACRAMENTO, Calif. (June 25, 2015) - UC Davis stem cell scientist Paul Knoepfler has been awarded $250,000 for glioma research from an organization begun 15 years ago by a 5-year-old girl with a deadly form of childhood cancer. Thu, 25 Jun 2015 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/10118 Dorsey Griffith 2015-06-25T00:00:00Z Leiserowitz receives WAGO award http://www.ucdmc.ucdavis.edu/publish/news/cancer/10089/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_10089 SACRAMENTO, Calif. (June 15, 2015) - Gary Leiserowitz, chief of gynecologic oncology and interim chair of the Department of Obstetrics and Gynecology, received the Western Association of Gynecologic Oncologists (WAGO) James F. Nolan Award June 12 at the 2015 Annual Meeting in Santa Rosa. Mon, 15 Jun 2015 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/10089 Susan Mar 2015-06-15T00:00:00Z UC Davis Division of Pediatric Hematology-Oncology welcomes new chief http://www.ucdmc.ucdavis.edu/publish/news/cancer/10082/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_10082 SACRAMENTO, Calif. (June 15, 2015) - Marcio H. Malogolowkin, an international leader in the treatment of rare pediatric liver tumors, has joined UC Davis as the new chief of the UC Davis Division of Pediatric Hematology and Oncology. Mon, 15 Jun 2015 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/10082 Inessa Samusenko 2015-06-15T00:00:00Z Revealing kidney cancer's secret http://www.ucdmc.ucdavis.edu/publish/news/cancer/10017/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_10017 SACRAMENTO, Calif. (May 14, 2015) - An international team of scientists, led by UC Davis nephrologist Robert Weiss, have used a sophisticated combination of proteomics and metabolomics to show how renal cell carcinoma (RCC) reprograms its metabolism and evades the immune system. In addition, the study found that cancer grade has a major impact on this reprogramming. These results, published in the journal Cancer Research, point to new therapeutic options for this particularly deadly cancer. Thu, 14 May 2015 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/10017 Dorsey Griffith 2015-05-14T00:00:00Z Surgery for terminal cancer patients still common http://www.ucdmc.ucdavis.edu/publish/news/cancer/9965/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9965 SACRAMENTO, Calif. (May 1, 2015) - The number of surgeries performed on terminally ill cancer patients has not dropped in recent years ­, despite more attention to the importance of less invasive care for these patients to relieve symptoms and improve quality of life. But new research from UC Davis also finds that the morbidity and mortality among patients with terminal cancer has declined because surgeons are selecting to operate on healthier patients. Fri, 01 May 2015 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9965 Dorsey Griffith 2015-05-01T00:00:00Z NCI funding boosts breast CT scanning research and development http://www.ucdmc.ucdavis.edu/publish/news/cancer/9960/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9960 SACRAMENTO, Calif. (April 29, 2015) - John M. Boone, a UC Davis medical physicist and professor of radiology, has been awarded a $2.88 million grant from the National Cancer Institute to further develop and research computed tomography (CT) to detect breast cancer. Wed, 29 Apr 2015 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9960 Dorsey Griffith 2015-04-29T00:00:00Z Comprehensive genomic tumor profiling comes to UC Davis http://www.ucdmc.ucdavis.edu/publish/news/cancer/9915/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9915 SACRAMENTO, Calif. (April 20, 2015) - The UC Davis Comprehensive Cancer Center and the Department of Pathology and Laboratory Medicine have entered into a collaboration with Foundation Medicine, a leading molecular information company. The collaboration brings comprehensive genomic profiling into standard of care at UC Davis, allowing physicians to prescribe the most effective, targeted cancer treatments to patients based on the genomic information specific to each individual’s cancer. Mon, 20 Apr 2015 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9915 Dorsey Griffith 2015-04-20T00:00:00Z UC Davis researchers win grant to answer key questions in surveillance of small lung nodules http://www.ucdmc.ucdavis.edu/publish/news/cancer/9913/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9913 SACRAMENTO, Calif. (April 15, 2015) - Two UC Davis researchers will help run a major national study to improve surveillance practices for patients with small lung nodules identified on CT imaging and extremely low risk for lung cancer. Wed, 15 Apr 2015 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9913 Dorsey Griffith 2015-04-15T00:00:00Z Conquer Cancer Foundation selects UC Davis med student for award http://www.ucdmc.ucdavis.edu/publish/news/cancer/9896/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9896 SACRAMENTO, Calif. (April 7, 2015) - The Conquer Cancer Foundation has selected UC Davis medical student Angel Morán for the 2015 American Society of Clinical Oncology (ASCO) Medical Student Rotation for Underrepresented Populations. Tue, 07 Apr 2015 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9896 Susan Mar 2015-04-07T00:00:00Z Small RNA plays big role suppressing cancer http://www.ucdmc.ucdavis.edu/publish/news/cancer/9862/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9862 SACRAMENTO, Calif. (April 2, 2015) - The micro RNA miR-22 has long been known for its ability to suppress cancer. However, questions remain about how it achieves this feat. For example, which molecules are regulating miR-22, and which are miR22 targets? Thu, 02 Apr 2015 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9862 Dorsey Griffith 2015-04-02T00:00:00Z Protein may improve liver regeneration http://www.ucdmc.ucdavis.edu/publish/news/cancer/9856/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9856 SACRAMENTO, Calif. (March 31, 2015) - Researchers at UC Davis have illuminated an important distinction between mice and humans: how human livers heal. The difference centers on a protein called PPARα, which activates liver regeneration. Normally, mouse PPARα is far more active and efficient than the human form, allowing mice to quickly regenerate damaged livers. However, the research shows that protein fibroblast growth factor 21 (FGF21) can boost the regenerative effects of human PPARα. Tue, 31 Mar 2015 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9856 Dorsey Griffith 2015-03-31T00:00:00Z UC Davis scientists describe novel drug mechanism that fights brain cancer http://www.ucdmc.ucdavis.edu/publish/news/cancer/9777/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9777 SACRAMENTO, Calif. (March 3, 2015) - Researchers at UC Davis have developed and characterized a molecule that interferes with the internal regulation of cancer cells, causing them to self-destruct. This novel mechanism was found to be effective against glioma cells – responsible for a usually fatal type of brain cancer – and could be applicable to other highly aggressive cancers. Tue, 03 Mar 2015 00:00:00 PST http://www.ucdmc.ucdavis.edu/publish/news/cancer/9777 Dorsey Griffith 2015-03-03T00:00:00Z UC Davis designated a Lung Cancer Screening Center http://www.ucdmc.ucdavis.edu/publish/news/cancer/9715/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9715 SACRAMENTO, Calif. (February 11, 2015) - UC Davis Health System has been endorsed by the American College of Radiology as a designated lung cancer screening center, the only of its kind currently in the greater Sacramento area. Wed, 11 Feb 2015 00:00:00 PST http://www.ucdmc.ucdavis.edu/publish/news/cancer/9715 Dorsey Griffith 2015-02-11T00:00:00Z California breast density law slow to have an impact http://www.ucdmc.ucdavis.edu/publish/news/cancer/9667/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9667 SACRAMENTO, Calif. (January 28, 2015) - Ten months after California legislators enacted a controversial law mandating that radiologists notify women if they have dense breast tissue, UC Davis researchers have found that half of primary care physicians are still unfamiliar with the law and many don’t feel comfortable answering breast density-related questions from patients. Wed, 28 Jan 2015 00:00:00 PST http://www.ucdmc.ucdavis.edu/publish/news/cancer/9667 Susan Mar 2015-01-28T00:00:00Z Moon Chen's research featured in ASCO's 2015 cancer progress report http://www.ucdmc.ucdavis.edu/publish/news/cancer/9643/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9643 SACRAMENTO, Calif. (January 21, 2015) - UC Davis professor Moon Chen’s research on the under-representation of minorities in clinical trials appears in the American Society in Clinical Oncology (ASCO)’s annual cancer progress report released Tuesday. Wed, 21 Jan 2015 00:00:00 PST http://www.ucdmc.ucdavis.edu/publish/news/cancer/9643 Susan Mar 2015-01-21T00:00:00Z Too much, too little, just right http://www.ucdmc.ucdavis.edu/publish/news/cancer/9553/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9553 SACRAMENTO, Calif. (December 15, 2014) - Scientists have long known the p53 protein suppresses tumors. However, a recent animal study by UC Davis researchers has uncovered a complicated relationship between p53 and another protein, Rbm38, highlighting how the body calibrates protein levels. Too much Rbm38 reduces p53 levels, increasing the risk of cancer. Too little Rbm38 allows p53 overexpression, causing premature aging. The study was published in the journal PNAS on Dec. 15.  Mon, 15 Dec 2014 00:00:00 PST http://www.ucdmc.ucdavis.edu/publish/news/cancer/9553 Susan Mar 2014-12-15T00:00:00Z 'Tis the season to indulge in walnuts http://www.ucdmc.ucdavis.edu/publish/news/cancer/9471/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9471 SACRAMENTO, Calif. (November 13, 2014) - Researchers at UC Davis and other institutions have found that diets rich in whole walnuts or walnut oil slowed prostate cancer growth in mice. In addition, both walnuts and walnut oil reduced cholesterol and increased insulin sensitivity. Thu, 13 Nov 2014 00:00:00 PST http://www.ucdmc.ucdavis.edu/publish/news/cancer/9471 Susan Mar 2014-11-13T00:00:00Z UC Davis "out-of-the-box thinker" wins cancer research award http://www.ucdmc.ucdavis.edu/publish/news/cancer/9464/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9464 SACRAMENTO, Calif. (November 12, 2014) - UC Davis medical oncologist Jonathan Riess is the recipient of a 2014 Young Innovators Team Award for Lung Cancer Research, and will share a $500,000 for translational lung cancer research with two other physician-scientists. Wed, 12 Nov 2014 00:00:00 PST http://www.ucdmc.ucdavis.edu/publish/news/cancer/9464 Susan Mar 2014-11-12T00:00:00Z Lung cancer screening for Medicare patients coming soon to UC Davis http://www.ucdmc.ucdavis.edu/publish/news/cancer/9459/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9459 SACRAMENTO, Calif. (November 10, 2014) - UC Davis Medical Center is preparing to screen seniors on Medicare who meet the criteria for lung cancer screening using low-dose computed tomography (CT). Mon, 10 Nov 2014 00:00:00 PST http://www.ucdmc.ucdavis.edu/publish/news/cancer/9459 Susan Mar 2014-11-10T00:00:00Z Immunotherapy for cancer toxic with obesity http://www.ucdmc.ucdavis.edu/publish/news/cancer/9429/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9429 SACRAMENTO, Calif. (November 3, 2014) - Immunotherapy that can be effective against tumors in young, thin mice can be lethal to obese ones, a new study by UC Davis researchers has found. [en español] Mon, 03 Nov 2014 00:00:00 PST http://www.ucdmc.ucdavis.edu/publish/news/cancer/9429 Susan Mar 2014-11-03T00:00:00Z UC Davis researchers examine risks, benefits of chemotherapy for early-stage breast cancer http://www.ucdmc.ucdavis.edu/publish/news/cancer/9413/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9413 SACRAMENTO, Calif. (October 31, 2014) - Treatment for early stage breast cancer is highly effective, and for many women considering treatment choices, chemotherapy may add little to an already high long-term survival rate. Joy Melnikow, professor in the Department of Family and Community Medicine and Director of the Center for Healthcare Policy and Research at UC Davis, is working to define the potential long-term harms of chemotherapy for these patients, so they can be weighed against the potential benefits. Fri, 31 Oct 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9413 Dorsey Griffith 2014-10-31T00:00:00Z Study on Western diet and role in GI cancer funded http://www.ucdmc.ucdavis.edu/publish/news/cancer/9408/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9408 SACRAMENTO, Calif. (October 28, 2014) - The National Cancer Institute (NCI) has awarded a $2.7 million grant to UC Davis researchers to investigate how the so-called Western diet, which is high in fat and sugar, increases the risk of developing liver and gastrointestinal (GI) cancers. In addition, the researchers will study whether bifidobacteria, a common family of bacteria in the human gut, can be enriched to prevent cancer. Tue, 28 Oct 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9408 Dorsey Griffith 2014-10-28T00:00:00Z Anti-cancer drug found effective against common stem cell transplant complication http://www.ucdmc.ucdavis.edu/publish/news/cancer/9394/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9394 SACRAMENTO, Calif. (October 24, 2014) - Researchers at UC Davis have found that the drug bortezomib effectively treats chronic graft-versus-host disease (GVHD), a common and debilitating side effect from allogeneic hematopoietic stem cell transplants. Fri, 24 Oct 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9394 Susan Mar 2014-10-24T00:00:00Z Distinguished cancer prevention researcher to lead public health sciences at UC Davis http://www.ucdmc.ucdavis.edu/publish/news/cancer/9361/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9361 SACRAMENTO, Calif. (October 21, 2014) - Brad Pollock, a leading researcher on the incidence and control of childhood and adolescent cancer, has become chair of the Department of Public Health Sciences at the UC Davis School of Medicine. Tue, 21 Oct 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9361 Karen Finney 2014-10-21T00:00:00Z NCI awards UC Davis $1.5 million to innovate robotic surgery for head and neck cancers http://www.ucdmc.ucdavis.edu/publish/news/cancer/9378/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9378 SACRAMENTO, Calif. (October 21, 2014) - The National Cancer Institute (NCI) has awarded UC Davis principal investigators Laura Marcu and Gregory Farwell $1.5 million to adapt UC Davis-developed biophotonic technology to a robotic surgical device in hopes of dramatically improving the precision of head and neck cancer surgery. Tue, 21 Oct 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9378 Susan Mar 2014-10-21T00:00:00Z Cancer Center wins $1.7 million NCI grant to study novel cancer treatment http://www.ucdmc.ucdavis.edu/publish/news/cancer/9337/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9337 SACRAMENTO, Calif. (October 10, 2014) - A multidisciplinary team at UC Davis will embark on research to determine whether combining a novel type of immunotherapy with radiation and chemotherapy can make treatment for sarcoma, breast and pancreatic cancers more effective. Fri, 10 Oct 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9337 Susan Mar 2014-10-10T00:00:00Z Cancer center's Brain Innovation Group funded for brain tumor tool http://www.ucdmc.ucdavis.edu/publish/news/cancer/9287/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9287 SACRAMENTO, Calif. (September 24, 2014) - The UC Davis Comprehensive Cancer Center’s Brain Innovation Group has received a grant from the National Cancer Institute (NCI) to improve brain cancer surgery and treatment using UC Davis-developed biophotonic technology. Wed, 24 Sep 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9287 Susan Mar 2014-09-24T00:00:00Z UC Davis-developed target leukemia treatment shows promise http://www.ucdmc.ucdavis.edu/publish/news/cancer/9243/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9243 SACRAMENTO, Calif. (September 11, 2014) - Noriko Satake, UC Davis pediatric oncologist and researcher, has demonstrated in laboratory studies that a new, targeted treatment for leukemia is effective. Thu, 11 Sep 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9243 Susan Mar 2014-09-11T00:00:00Z Introducing the multi-tasking nanoparticle http://www.ucdmc.ucdavis.edu/publish/news/cancer/9051/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9051 SACRAMENTO, Calif. (August 26, 2014) - mKit Lam and colleagues from UC Davis and other institutions have created dynamic nanoparticles (NPs) that could provide an arsenal of applications to diagnose and treat cancer. Built on an easy-to-make polymer, these particles can be used as contrast agents to light up tumors for MRI and PET scans or deliver chemo and other therapies to destroy tumors. In addition, the particles are biocompatible and have shown no toxicity. The study was published online today in Nature Communications. Tue, 26 Aug 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9051 Dorsey Griffith 2014-08-26T00:00:00Z California isn't measuring up in the fight against cancer http://www.ucdmc.ucdavis.edu/publish/news/cancer/9193/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9193 SACRAMENTO, Calif. (August 21, 2014) - In a media briefing at the UC Davis Comprehensive Cancer Center, the American Cancer Society Cancer Action Network released How Do You Measure Up?, an annual report that scores each state on how they are doing in the fight against cancer. Thu, 21 Aug 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9193 Susan Mar 2014-08-21T00:00:00Z Novel drug action against solid tumors explained http://www.ucdmc.ucdavis.edu/publish/news/cancer/9171/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9171 SACRAMENTO, Calif. (August 11, 2014) - Researchers at UC Davis, City of Hope, Taipai Medical University and National Health Research Institutes in Taiwan have discovered how a drug that deprives the cells of a key amino acid specifically kills cancer cells. Mon, 11 Aug 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9171 Susan Mar 2014-08-11T00:00:00Z Pan awarded grant to test 'smart' chemotherapy drug for bladder cancer http://www.ucdmc.ucdavis.edu/publish/news/cancer/9168/?WT.rss_f=UC Davis Comprehensive Cancer Center&WT.rss_ev=a&WT.rss_a=Article_9168 SACRAMENTO, Calif. (August 7, 2014) - UC Davis Comprehensive Cancer Center oncologist Chong-Xian Pan has received a $650,000 grant from the VA Northern California Health Care System to conduct the first clinical trial of a novel chemotherapy-delivery drug he developed for bladder cancer patients. Thu, 07 Aug 2014 00:00:00 PDT http://www.ucdmc.ucdavis.edu/publish/news/cancer/9168 Susan Mar 2014-08-07T00:00:00Z